Why It Starts Here, in the West Midlands for Data‑Driven Healthcare Innovation

By: Kathryn Wagstaff – Senior Business Development Manager, West Midlands Growth Company

The West Midlands is fast emerging as one of the UK’s most compelling destinations for life sciences and data-driven healthcare, boasting a complete ecosystem from research to real-world application.

A Rich, Data-Ready Population

With an estimated 4.7 million residents—one of the most ethnically diverse and demographically stable populations outside London—the region offers companies direct access to a broad pool for clinical trials, real-world evidence, and genomic research. Such diversity enhances the quality of outcomes research, especially in domains like personalised medicine and diagnostics.

A Leading UK Hub for Clinical Trials

The West Midlands hosts 80 local hospitals and clinics, plus 35 regional clinical research centres. It stands among the top locations in the UK for clinical trial volume, this density of clinical infrastructure accelerates time‑to‑market for novel therapies, medical devices, and diagnostic tools.

MedTech Strength and Digital Health Leadership

About 61% of the region’s healthcare sector is MedTech-focused—generating roughly 8% of UK’s MedTech turnover overall. Paired with UK’s largest 5G testbed, deep AI capabilities, immersive tech development and advanced manufacturing, the West Midlands supports a thriving ecosystem of digital health, surgical robotics, wearables, and diagnostics innovation.

Academic Excellence, Talent Pipeline, Lower costs

The region unites eight top-tier universities, including four medical schools, all bolstering collaboration between academia and industry. Annually the region produces 87,000+ STEM graduates, among them 11,000 medical science graduates. Compared to London, operating costs—including real estate and recruitment—are 30–40% lower, offering businesses scalable talent and affordability.

Scale-Up Support and Investment Readiness

The region is supported by targeted initiatives such as the Global Growth Programme, offering fully funded support for companies entering or expanding into UK life sciences and data-driven healthcare.

New businesses also benefit from free expert advisory services, navigating property, recruitment, public funding, and partnerships—with introductions to local property agents, universities, and public-sector bodies provided at no cost.

Economic Impact and Growth Outlook

The West Midlands’ life sciences and healthcare economy is worth approximately £10.3 billion, employing over 23,600 people in HealthTech and life sciences—with projections of nearly 10,000 additional roles by 2030. Nationally, the UK’s life sciences industry is estimated at £108 billion, leading globally in innovation and research output.

Ready to Set Up in the West Midlands?

If you’re exploring your next move into life sciences, digital health or MedTech innovation, reach out to the Life Sciences team to access tailored support and facilitate your entry into the UK market.

By locating in the West Midlands, you’re not just entering the UK market—you’re stepping into a gateway for global impact in life sciences and healthcare innovation.

About the author:

Kathryn Wagstaff is the Senior Business Development Manager (Life Sciences) for West Midlands Growth Company (WMGC). WMGC role is to retain and attract Life Science businesses to the West Midlands. In the blog below Kathryn gives just some of the reasons why the West Midlands is the beating heart of UKs Life Sciences developments.

For further information Kathryn.wagstaff@wmgrowth.com 

Author

Leave A Comment

Shabna Raja

Advisory Partner,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Shabna Raja is a senior leader in enterprise transformation within Life Sciences, with over 20 years’ experience spanning pharma, consumer health and large-scale digital programmes.

She specialises in bridging strategy and execution – helping organisations translate AI, data and digital innovation into tangible business outcomes. Her work focuses on complex transformation
initiatives across commercial, data and operating model domains within regulated environments.

Shabna spent seven years at GSK, where she played a key role in transformation programmes, including as part of the Consumer Health joint venture with Pfizer — one of the most significant integrations in the sector. This experience provided her with deep expertise in  organisational change, integration and operating model evolution at global scale.

More recently, she has spent over three years working closely with Haleon through a strategic
services partnership, leading enterprise client engagement and managing a multi-million-pound account while supporting transformation across a newly independent global organisation.

Her experience spans the end-to-end life sciences value chain, including R&D, commercial, supply chain and patient engagement, giving her a holistic perspective on how technology and transformation can unlock value across the industry.

Amjad Khan

Executive Partner,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Amjad Khan is a UK-based entrepreneur, AI strategist, and senior technology leader with over 15 years of experience at Pfizer, where he held multiple leadership roles across digital strategy and transformation. As Global Digital Client Partner, he was responsible for digital strategy and execution across Global Business Units covering Vaccines, Hospital, and Medical Affairs. Most notably, he led the commercial launch for the Covid franchise transforming and accelerating the model for how new medicines are brought to market.

Following his tenure at Pfizer, Amjad channelled his expertise into building at the frontier of AI. His work spans AI leadership, stakeholder engagement, and agile delivery helping organisations adopt
and scale emerging  technologies to drive meaningful outcomes.

Dr. Richard Fallon | Business Consultant | WM Life Sciences

Dr. Richard Fallon

Co Founder, Life Sciences Week 
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Dr Richard Fallon is an entrepreneur and ecosystem builder who connects industry leaders, investors and public-sector stakeholders to accelerate collaboration and commercial growth.

As the Founder of the Technology Supply Chain and co-founder of the Innovation Awards, he has spent more than two decades convening influential networks that help emerging businesses find capital, strategic partners and new routes to market.

Richard’s work spans leadership and consultancy across major organisations, alongside building membership and partnership platforms that bring universities, industry and investors into the same room – and turn conversations into practical outcomes.

With his focus on life sciences, Richard supports organisations and people driving breakthroughs in healthcare, biotechnology, medical technology and advanced research. He is passionate about creating the conditions for transformative ideas to move from concept to real-world impact – by connecting innovators with the funding, expertise and opportunities they need to scale.

Through Life Sciences Week, Richard is championing the UK’s world-class life sciences community and helping position it at the forefront of innovation, investment and patient outcomes.

Amy Deakin | Chief of Staff | WM Life Sciences

Amy Deakin

Event Managing Director,
Life Sciences Week
+44 (0) 121 227 4156
info@lifesciencesweek.co.uk

Bio

Amy Deakin is a Birmingham-based leader specialising in building partnerships and fostering innovation in the life sciences sector. With a degree in Sport and Exercise Science, Amy brings a grounded understanding of human health and performance to her work and a strong interest in the developments shaping healthcare today.

Amy is Managing Director of Life Sciences Week, part of the One Thousand Trades Group, and also serves as Director of One Thousand Trades Events. In these roles, she convenes researchers, clinicians and industry leaders to strengthen collaboration, unlock new partnerships and help accelerate real-world innovation across the life sciences ecosystem.

Her career spans both commercial and third-sector environments. She began in automotive design, delivering projects for Volkswagen, McLaren, Bentley and Jaguar Land Rover, before moving into the third sector with Acorns Children’s Hospice. She later joined Western Union, working as a Partnerships Manager for international payments

An avid netballer, Amy is a committed advocate for health and wellbeing – bringing energy, clarity and connection to everything she builds, and actively involved as a participant in health related research studies.

    Award Category Voting

    Here's a list of all categories you can vote for. Simply click each category to cast your vote. Voting in each category is not mandatory, so please feel free to click just the category that interests you.

    Day you've not voted in, will be denoted with an ❌

    If you're having issues submitting the form, please ensure all the category boxes are closed and try again.

    Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

    No VoteProf. Alex RichterBlack Space TechnologyAston Vision Sciences

    Celebrating an emerging leader making significant contributions to the field through research, innovation, or leadership.

    Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

    No VoteShashank Chaganty – VichagLeah Vanono - PBS InnovationsKloe Avon- KZ Organics

    Honouring successful cross-sector partnerships driving advancements in life sciences, from academia to industry.

    No VoteProf Liam Grover- WMHTIAJudith Stewart- Health Innovation West MidlandsAdam McGuinness - Plug and Play

    Awarding an individual or organisation for exceptional long-term impact on the industry.

    No VoteDavid KidneyMedilink MidlandsUniversity of Birmingham

    Highlighting innovations in treatments, diagnostics, or healthcare delivery that have significantly improved patient outcomes.

    No VoteJean-Louis Duprey - Linear DiagnosticsSian Dunning - MD-TECKarim Vissangy - HoloMedix

    Your Details